Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting -0.91. At the close of trading, the stock’s price was $5.40, to imply an increase of 25.29% or $1.09 in intraday trading. The BDMD share’s 52-week high remains $13.52, putting it -150.37% down since that peak but still an impressive 80.56% since price per share fell to its 52-week low of $1.05.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) trade information

After registering a 25.29% upside in the last session, Baird Medical Investment Holdings Limited (BDMD) has traded red over the past five days. The 5-day price performance for the stock is 20.27%, and 5.06% over 30 days. With these gigs, the year-to-date price performance is -28.95%.

BDMD Dividends

Baird Medical Investment Holdings Limited has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Going by data provided on Apr 30, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 15.93 shares. This is just over 0.04% of the total shares, with a market valuation of $86027.0